Article
Advances in Helicobacter pylori Antimicrobial Resistance Detection: From Culture‐Based to Multi‐Omics‐Based Technologies
1 Jan 2025
Abstract excerpt
Helicobacter pylori (H. pylori), a proven carcinogenic microbe, necessitates antimicrobial treatment once infected. However, H. pylori worldwide currently faces serious antibiotic resistance (AMR), requiring infected patients to undergo antibiotic susceptibility testing (AST) to guide therapy. Currently, the recommended ASTs for H. pylori are culture-based methods, which are time-consuming, complicated, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
